House of Pearl Fashions (HOPFL), a multinational ready to wear apparel manufacturing conglomerate, has signed a multi-year license agreement with Geoffrey Beene, LLC for men's casual slacks, casual shorts and dress slacks under the Geoffrey Beene Label.

The company signed deal through its US-based subsidiary christened House of Pearl Fashions (US) Ltd.

It should be noted that Geoffrey Beene, Inc. was incorporated in 1963 and is currently operated by its president and CEO, Tom Hutton.

India's largest cable company, Polycab Wires and Cables, has entered into an alliance with France's Nexans to set up Euro 60-million (Rs 400-crore) project near Baroda in Gujarat.

The joint venture, with its headquarters in Vadodara in the state of Gujarat, will cover the manufacturing and marketing of special cables for the shipbuilding, material handling, railways and windpower industries.

Voltas, part of the Tata group, has informed that its textile machinery division has entered into a partnership deal with Germany's Thies to sell and service Thies products in India.

Under the arrangement, Thies will supply products such as fabric dyeing machines, jiggers and bleaching plants in India.

According to an official statement, the partnership will use the market potential of processing segments, which offer unique opportunities for India to augment its share in the international textiles trade.

The announcement by Aurobindo Pharma to enter in to a strategic deal with US-based pharmaceutical major Pfizer helped its shares price on the Bombay Stock Exchange on Wednesday. The deal would allow selling of generic medicines, used for cardiovascular disease and central nervous system disorders, in the US and European market.

The global generic market is currently worth $270 billion and expected to grow over $500 billion in the next five years. Pfizer holds considerable shares in drug market, selling $10 billion non-exclusive drug annually.

In light of the highly uncertain global economic conditions, Hexaware Technologies Limited (HTL), an IT and BPO service provider, has announced that it will implement cost control measures to improve its current utilization.

In a disclosure to the Stock Exchange, the Mumbai based company said that it will put about 350 people who are currently non-billable on a virtual bench and retain them in the organization though there are no immediate billable opportunities for them.

The US Food and Drug Administration (USFDA) has given tentative approval to Aurobindo Pharma, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), to market Escitalopram Oxalate tablets in variable strengths.

Aurbindo will market the pills in dosages of 5mg, 10mg and 20mg.